The COVID-19 pandemic caused by the SARS-Cov-2 virus requires the development of strategies not only to detect and inactivate the virus, but also to contain its spread quickly and effectively.
Therefore, at Biosckin, Molecular and Cell Therapies, S.A. we focus on promoting proven medical diagnostic devices and specialized prevention products as a priority for the well-being and safety of all.
Biosckin, Molecular and Cell Therapies, S.A. has at its disposal the BSK Gel, alcohol-based antiseptic solution with isopropyl alcohol for hand sanitization. BSK Gel is produced in a controlled laboratory and is registered with the Directorate-General for Health and CIAV. It is a product formulated to ensure a correct sanitation in a hospital, food, and household, among others. BSK Gel has bactericidal, virucidal and fungicidal activity. BSK Gel with an alcoholic concentration of more than 70% is composed of isopropyl alcohol, hydrogen peroxide, glycerin and ultrapure water.
BSK Gel is available in packs of 5 liters, 1 liter, 500, 250 and 75 milliliters. Packages of 1L, 500 mL and 250 mL can be obtained with or without dispenser at the same value.
VIRUS TRANSPORT MEDIUM FOR DIAGNOSIS
Biosckin, Molecular and Cell Therapies, S.A. produces in its Laboratory, in a controlled environment, a Virus Transport Medium (VTM) for collection and analysis of human nasopharyngeal samples. The BSK VTM is intended for the transport of human samples containing viruses from the place of collection to the laboratory of analysis. BSK VTM is marketed in boxes of 100 units with 1.5 mL capacity with sterile maintenance medium with or without virus inactivation.
BSK VTM is based on Hanks Balanced Salt Solution (HBSS) with calcium and magnesium and contains heat-inactivated fetal bovine serum, gentamycin and amphotericin B. The composition and the manufacturing of the BSK VTM follows the national and international regulatory authorities’ recommendations (INFARMED, WHO and the CDC).
The product is provided as a liquid in a sterile 10 ml flat bottom tube with or without a swab to provide a maximum range of possibilities to collect samples.
BSK VTM is intended for in vitro Diagnosis. A quality control of the sterility of all batches of the BSK VTM is constantly carried out.
Covid-19 Rapid Antigen Test
At Biosckin, Molecular and Cell Therapies, S.A. we carry out antigen research tests developed for the diagnosis of SARS-CoV-2.
SARS-CoV-2 Antigen Test is an immunochromatographic test for in vitro diagnostic, which detects specific proteins of the SARS-CoV-2 virus, produced by the replicating virus in the respiratory tract. This test involves taking samples from the respiratory tract (exudate from the nasopharynx) that do not need to be subjected to the nucleic acid extraction process. The SARS-CoV-2 Antigen Test with low complexity of technical execution, allows to obtain results in a short period of time (between 10 to 15 minutes), being visual reading or optical reading in portable equipment.
The collection of the respiratory sample and the tests must comply with all safety rules applicable to samples suspected of the presence of a class 2 pathogen. The tests are therefore performed by a health professional with experience and competence to collect the sample, carrying out the test and interpreting the results.
Biosckin, Molecular and Cell Therapies, S.A. has a team of accredited, qualified and experienced healthcare professionals who apply the test in a safe and controlled environment. The SARS-CoV-2 Antigen Test is therefore strictly for professional use.
This medical diagnostic device allows results to be obtained in just 10 to 15 minutes, being indicated for the detection of active infections in symptomatic individuals, with suspected COVID-19 infection. Due to its speed and simplicity, this medical device can be seen as a very useful tool for the benefit of all in the fight against a worldwide pandemic that requires responsible and conscious action by each one of us.